Storia in 16 fonti

‘No discussions’ over AstraZeneca-Bristol Myers deal, senior source says

Earlier reports said the two drugmakers held talks about a possible deal that would create a pharmaceutical behemoth. Read more at straitstimes.com. Read more at straitstimes.com.

Raccontata da

sueddeutsche.de+4 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

straitstimes.comStai leggendo8 g fa

‘No discussions’ over AstraZeneca-Bristol Myers deal, senior source says

Earlier reports said the two drugmakers held talks about a possible deal that would create a pharmaceutical behemoth. Read more at straitstimes.com. Read more at straitstimes.com.

originale

Timeline cronologica

domenica 2 agosto 2026·cnbc.com
AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports
U.K. pharmaceutical giant AstraZeneca is considering a deal to merge with its U.S. rival Bristol Myers Squibb.
domenica 2 agosto 2026·straitstimes.com
Pharma giants AstraZeneca, Bristol Myers Squibb in talks on $512 billion megadeal: Report
The deal could create one of the world’s biggest pharmaceutical groups with a combined value of nearly US$400 billion. Read more at straitstimes.com. Read more at straitstimes.com.

‘No discussions’ over AstraZeneca-Bristol Myers deal, senior source says

Confronto fonti

‘No discussions’ over AstraZeneca-Bristol Myers deal, senior source says

Timeline cronologica

AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports

Pharma giants AstraZeneca, Bristol Myers Squibb in talks on $512 billion megadeal: Report

'No discussions' over AstraZeneca-Bristol Myers deal, senior source says

AstraZeneca and Bristol Myers Squibb merger talks denied

‘No discussions’ ongoing for AstraZeneca-Bristol Myers merger: Reuters

AstraZeneca Held Talks to Combine With Bristol Myers Squibb, FT Says, Citing Sources

Pharma giants AstraZeneca and Bristol-Myers in reported merger talks

AstraZeneca, Bristol Myers Squibb Reportedly in Talks for $400 Billion Merger - AstraZeneca (NYSE:AZN)

AstraZeneca, Bristol Myers are in talks about merger — report

AstraZeneca said to have explored Bristol Myers merger | Fortune

An AstraZeneca-Bristol Myers megamerger? Wall Street isn’t thrilled.

AstraZeneca Held Talks to Combine With Bristol Myers Squibb, FT Says, Citing Sources

Astrazeneca explores $400bn megadeal with US rival

AstraZeneca in talks over £300bn mega-merger with US rival – reports

AstraZeneca shares drop 7% after report on $400 billion merger talks with Bristol Myers Squibb

AstraZeneca, BMS discuss $400B pharma mega-deal

AstraZeneca negocia fusão de US$ 400 bi com a americana Bristol Myers Squibb

AstraZeneca ‘in talks to create £300bn pharmaceutical giant’

Pharma: Mega-Fusion zwischen Astra Zeneca und Bristol Myers im Gespräch

AstraZeneca share prices drop amid £300bn mega-merger talks with US rival

$400 Billion Pharma Megadeal? Jefferies Calls Potential AstraZeneca-Bristol Myers Merger A "Head Scratcher"

Why Is Bristol-Myers Squibb Stock Surging Monday? - Bristol-Myers Squibb (NYSE:BMY), AstraZeneca (NYSE:AZ

Ações da AstraZeneca caem após notícia de possível fusão que criaria 4ª maior farmacêutica

AstraZeneca shares fall amid reports of $400bn Bristol Myers Squibb merger talks

AstraZeneca Stock Nosedives On Mega-Merger Rumor